- H81 -

ANNOUNCING The first biomarker based trial for MECFS Rapamycin pilot trial Learn more. Read our 2024 yearend newsletter We are driving treatmentfocused research for MECFS Developing 1stinkindAnimal Models Finding Key TreatableMechanisms Defining Subsets Our mouse models will change the face of MECFS research. Animal models will spur discovery and attract pharmaceutical companies to study MECFS and similar diseases. Model 1 PUBLICATION PENDINGPostExertional Malaise Model 2 Orthostatic IntolerancePOTS Model 3 Neuroinflammation Brain Fog The Simmaron Difference We are uniting patients doctors and scientists in a quest for breakthroughs in MECFS neuroimmune disease.